SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
HXY
Lv1
28 积分
2021-11-15 加入
最近求助
最近应助
互助留言
The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma – A systematic review
4天前
已完结
Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients With Resectable NSCLC: A Phase 2 Clinical Trial
14天前
已完结
Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma
14天前
已完结
Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1)
1个月前
已完结
Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas
1个月前
已完结
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer
1个月前
已完结
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
1个月前
已完结
Controlled delivery of a neurotransmitter–agonist conjugate for functional recovery after severe spinal cord injury
1个月前
已完结
Efficacy and Safety of Triple Antihypertensive Therapy with the Olmesartan/Amlodipine/Hydrochlorothiazide Combination
1个月前
已完结
Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i
1个月前
已完结
没有进行任何应助
速度真快
1个月前
帮大忙了
1个月前
帮大忙了
1个月前
速度真快,帮大忙了
1个月前
速度真快,帮大忙了
1个月前
速度真快,帮大忙了
1个月前
速度真快,帮大忙了
1个月前
感谢,速度真快
1个月前
速度真快,帮大忙了
1个月前
速度真快,帮大忙了
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论